[인터뷰]윤찬 대표 "자세추정 AI기술 'MORA' 수요 확실" 美서 MORA 수익 확보 시작…내년 'MORA-DTx' 허가 신청윤찬 에버엑스 대표가 근골격계질환 재활운동 치료 플랫폼 '모라'(MORA)를 설명하고 있다./뉴스1관련 키워드gbf관련 기사Why South Korea's Bio Industry Needs 10-Year Support Plans: Insights from GBF 2026The Future of Medicine: Why South Korea Must Invest in Innovative Drug DevelopmentHow South Korea's Regulatory Innovations are Shaping the Global Bio Market in 2026Unlocking Global Markets: Key Strategies for Successful FDA Approval in 2026Revolutionizing Drug Development: How Quantum Computing and AI Can Overcome the 4% Success Rate